Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability

This publication has 33 references indexed in Scilit:

• Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells
  Oncogene, 2002
• Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia
  Leukemia, 2002
• Analysis of p53/BAX in primary colorectal carcinoma: Low BAX protein expression is a negative prognostic factor in UICC stage III tumors
  International Journal of Cancer, 2002
• The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines
  Oncogene, 2002
• DNA damage and apoptosis
  Cell Death & Differentiation, 2001
• p53-dependent pathways of apoptosis
  Cell Death & Differentiation, 2001
• Overexpression of p53 predicts shorter survival in diffuse type gastric cancer
  British Journal of Surgery, 1998
• Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
  Journal of Clinical Investigation, 1996
• Expression of p53 protein as a prognostic factor in patients With gastric cancer
  European Journal Of Cancer, 1996
• Expression of the bcl‐2 gene family in normal and malignant breast tissue: Low bax‐α expression in tumor cells correlates with resistance towards apoptosis
  International Journal of Cancer, 1995